Nukleus Office solutions Complete Financial Statements
In FYNone, Nukleus Office solutions (NUKLEUS) reported revenue ₹20 Cr, net profit ₹2 Cr and EPS ₹5.50, with a net profit margin of 5.7% and ROE of 4.9%. Full financial statements from FY2022 to FY2026 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Nukleus Office solutions share price chart.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NUKLEUS Revenue, Net Profit & EBITDA — Year-on-Year Growth
NUKLEUS YoY (March 2026 vs Period) — revenue -42.9%, EBITDA -37.5%, expenses -44.4%. View NUKLEUS annual price range for the annual high/low range and current price position.
NUKLEUS Income Statement — Revenue, EBITDA & Net Profit
Nukleus Office solutions revenue ₹20 Cr, EBITDA ₹5 Cr, net profit ₹2 Cr, EPS ₹5.50 (None) — net profit margin 5.7%. Check Nukleus Office solutions marketcap in USD to track the company's total market size over time.
| Particulars | None | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|---|---|
| Revenue | 20 | 35 | 29 | 17 | 11 | 3 |
| Expenses | 15 | 27 | 22 | 14 | 10 | 3 |
| EBITDA | 5 | 8 | 7 | 3 | 1 | 0 |
| Operating Profit Margin % | 19.00% | 24.00% | 23.00% | 19.00% | 13.00% | 5.00% |
| Depreciation | 2 | 5 | 3 | 2 | 1 | 0 |
| Interest | 1 | 1 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 3 | 3 | 2 | 1 | 0 |
| Tax | 1 | 1 | 1 | 0 | 0 | 0 |
| Net Profit | 2 | 2 | 2 | 1 | 1 | 0 |
| Earnings Per Share (₹) | 5.50 | 5.30 | 7.53 | 19.71 | 42.04 | 6.65 |
NUKLEUS Balance Sheet — Assets, Liabilities & Shareholders' Equity
NUKLEUS total assets ₹77 Cr, total equity ₹41 Cr, total liabilities ₹ Cr (2026) — ROE 4.9%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 77 | 60 | 19 | 7 | 3 |
| Current Assets | 23 | 34 | 9 | 3 | 3 |
| Fixed Assets | 35 | 10 | 5 | 2 | 0 |
| Capital Work in Progress | 13 | 3 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 46 | 12 | 5 | 3 |
| LIABILITIES | |||||
| Total Liabilities | |||||
| Current Liabilities | 24 | 15 | 9 | 5 | 2 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 41 | 39 | 4 | 1 | 0 |
| Share Capital | 4 | 4 | 3 | 0 | 0 |
| Reserves & Surplus | 37 | 35 | 2 | 1 | 0 |
NUKLEUS Cash Flow Statement — Operating, Investing & Financing
Nukleus Office solutions operating cash flow ₹-8 Cr, investing ₹-9 Cr, financing ₹35 Cr, net cash flow ₹18 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | -8 | 4 | 1 | -1 |
| Investing Activities | -9 | -7 | -4 | -1 |
| Financing Activities | 35 | 8 | 3 | 2 |
| Net Cash Flow | 18 | 6 | 0 | 0 |